In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in remyelination research in multiple sclerosis.  In addition to answering questions submitted by members of our online communities, Travis and Brett looked in detail at the presentations on this topic recently delivered at the ECTRIMS Congress 2021.

After watching this video, please don’t hesitate to leave any questions you may have in the comments below.  Alternatively, you can engage and participate in the conversation being had on this video across our social channels, or email Brett directly at brett@mstranslate.com.au.  Community queries, insights, opinions and feedback are always welcomed!


Join the conversation on all things related to multiple sclerosis research by connecting with us on social media. You can find us on FacebookTwitterYouTubeInstagram and LinkedIn.

Learn more about Dr Travis Stiles and Novoron Bioscience by visiting their website (linked above), or by following them on social media – Facebook, Twitter and LinkedIn.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.